English | Español
Patient Daily | Aug 3, 2026

Novo Nordisk’s ziltivekimab fails Phase 3 trial, impacting inflammation drug developers
Patient Daily | Aug 3, 2026

NICE criteria miss most younger women at risk for breast cancer, study finds
Patient Daily | Aug 3, 2026

BioNTech appoints Sobi CEO Guido Oelkers as new chief executive officer
Patient Daily | Aug 3, 2026

Biotech leaders respond to FDA’s Operation TrialBlazer clinical trial initiative
Patient Daily | Aug 3, 2026

'Me-too' drugs drive increased spending through higher prescribing, USC study finds
Patient Daily | Aug 3, 2026

Study links ancient evolutionary pressures to severe COVID-19 risk
Patient Daily | Aug 3, 2026

Analysts say AstraZeneca-Bristol Myers Squibb merger unlikely amid antitrust concerns
Patient Daily | Aug 3, 2026

Supernus and Indivior announce merger to form central nervous system-focused company

Trending
+ Regulatory
L. R. Alvarez | Jul 30, 2026

TPA's Ross Marchand on 340B: 'Taxpayers are picking up the tab for the program's many failures and mission creep'
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
J. R. Bair | Jul 28, 2026

Employers for Hospital Accountability: 'Participating hospitals are stockpiling far more assets than similar non-340B hospitals'
+ Pharmaceuticals
Patient Daily | Jul 30, 2026

Jefferies analysts say Daiichi Sankyo’s pipeline lags as cash flow nears peak